Citing Sources and Traceability for Monoclonal Antibody

Data Characteristics for This Category

Monoclonal antibody clinical trial data comes from various sources. These include official clinical trial registries (e.g., ClinicalTrials.gov, EU Clinical Trials Register), pharmaceutical company trial reports, academic journal papers, and regulatory agency review documents (e.g., FDA, EMA). Data update frequencies vary. Registry information might update weekly, while academic papers and review documents release in batches. Document structures differ. Registries typically provide structured tabular data, including fields for trial design, subject characteristics, interventions, and primary endpoints. Pharmaceutical company reports and academic papers are often unstructured PDF documents containing extensive text descriptions, charts, and tables. Key fields like NCT ID, Drug Name, Phase, Target, Adverse Events, and Efficacy Endpoints may have subtle naming and unit differences across sources, requiring standardization.

Constraints on "Citing Sources and Traceability"

The multi-source and heterogeneous nature of monoclonal antibody clinical trial data imposes specific constraints on citing sources and traceability. First, the large volume of unstructured documents requires the knowledge base to effectively process formats like PDF and accurately extract key information for citations. Second, inconsistent data fields and units across sources necessitate normalization during citation to avoid ambiguity from direct original text citations. For example, dosage units might differ between mg/kg and mg. Third, varying data update frequencies mean the knowledge base needs an update mechanism to ensure citation timeliness, especially for ongoing clinical trials. Finally, to ensure reliable traceability, the system must precisely point to the original document's source, including page numbers or paragraphs. This is particularly important for lengthy review documents, where only a filename is insufficient for effective traceability.

Configuration Settings

Configuration Item	Suggested Value	Rationale
`Chunk size` (Segment Length)	`500-800 characters`	Balances completeness of descriptive paragraphs in monoclonal antibody clinical trial reports with retrieval efficiency.
`Recall count` (Recall Count)	`Top 5-8 items`	Ensures coverage of multiple potentially relevant clinical trials or document segments, considering information dispersion.
`Similarity threshold` (Similarity Threshold)	`0.75-0.85`	Balances recall and precision, avoiding citations of irrelevant or low-relevance content.
`Rerank result count` (Rerank Return Count)	`Top 3 items`	Further focuses on the most relevant citation segments through a reranking model after initial recall.
`maxContext`	`4096 tokens`	Accommodates detailed descriptions in monoclonal antibody clinical trial-related texts, preventing truncation of critical information.
`document_id`	`Calibrated by measurement`	Ensures each clinical trial report or research paper has a unique identifier for precise traceability.

Three Common Mistakes

The answer lacks citations or citation content is empty. This happens when the knowledge base segment length is too small, splitting key information and preventing complete recall.
Citation content has low relevance to the question, or cites clearly irrelevant documents. This happens when the similarity threshold is set too low, recalling a large amount of noisy data.
The retrieval node in the workflow does not correctly reference the datasetid variable, causing knowledge base retrieval to fail. This happens due to a variable name typo or if the variable is not defined globally.

How to Confirm Correct Configuration

For typical queries, check if the generated answer includes citations. Verify the consistency between the cited text and the original document content in the knowledge base, paying close attention to key data and conclusions.
Adjust the Similarity threshold (Similarity Threshold) and observe changes in the relevance of recalled items. Continue until recall is maintained while reducing irrelevant content.
Run a series of test questions containing different monoclonal antibody names and trial phases. Verify that the system consistently provides citations and allows tracing back to specific documents under various conditions.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.